The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation

J Thromb Haemost. 2016 Mar;14(3):531-45. doi: 10.1111/jth.13208. Epub 2016 Feb 15.

Abstract

ESSENTIALS: The lectin pathway's MASP-1/2 activates coagulation factors but the trigger of the activation is unknown. MASP-1/2 activation was assessed by quantifying complexes between MASPs and antithrombin/C1-inhibitor. Activated platelets and fibrin were demonstrated to activate MASP-1 and MASP-2 both in vitro and in vivo. These findings may represent a crossroad between the complement and the coagulation systems.

Background: The activated forms of the complement lectin pathway (LP) proteases MASP-1 and MASP-2 are able to cleave the coagulation factors prothrombin, fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor in vitro. In vivo studies also show that MASP-1 is involved in thrombogenesis.

Objectives: To clarify the not yet identified mechanisms involved in triggering activation of the LP during thrombotic reactions.

Methods: Novel sandwich-ELISAs for detection of complexes between MASP-1 or MASP-2 and the serpins C1 inhibitor (C1-INH) or antithrombin (AT), were used to specifically detect and quantify the activated forms of MASP-1 and MASP-2.

Results: Activated platelets were shown by flow cytometry to bind Ficolin-1, -2 and -3 but not MBL, which was associated with activation of MASP-1 and MASP-2. We also demonstrated that fibrin and the plasmin-generated fibrin fragment DD in plasma, bind and activate MASP-1 and MASP-2. As demonstrated by the ELISA and SDS-PAGE/Western blotting, the fibrin-associated activation was reflected in a specific inactivation by AT during clotting without the assistance of heparin. In all other cases the MASPs were, as previously reported, inactivated by C1-INH. In systemic lupus erythematosus patients with thrombotic disease and in polytrauma patients, the levels of activated MASP-1 and MASP-2 in complex with both AT and C1-INH were associated with markers of thrombotic disease and contact/coagulation system activation.

Conclusions: MASP-1 and MASP-2 are activated during blood clotting. This activation is triggered by activated platelets and by the generation of fibrin during thrombotic reactions in vitro and in vivo, and may represent a novel activation/amplification mechanism in thromboinflammation.

Keywords: blood coagulation; complement pathway; fibrin; mannose-binding lectin; mannose-binding protein-associated serine proteases; platelet activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antithrombin Proteins / metabolism
  • Blood Coagulation*
  • Blood Platelets / enzymology*
  • Blood Platelets / immunology
  • Case-Control Studies
  • Complement C1 Inhibitor Protein / metabolism
  • Complement Pathway, Mannose-Binding Lectin*
  • Enzyme Activation
  • Female
  • Fibrin / metabolism
  • Humans
  • Inflammation / blood
  • Inflammation / enzymology*
  • Inflammation / immunology
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / enzymology
  • Lupus Erythematosus, Systemic / immunology
  • Male
  • Mannose-Binding Protein-Associated Serine Proteases / immunology
  • Mannose-Binding Protein-Associated Serine Proteases / metabolism*
  • Middle Aged
  • Multiple Trauma / blood
  • Multiple Trauma / enzymology
  • Multiple Trauma / immunology
  • Platelet Activation*
  • Protein Binding
  • Signal Transduction
  • Thrombosis / blood
  • Thrombosis / enzymology*
  • Thrombosis / immunology
  • Time Factors
  • Young Adult

Substances

  • Antithrombin Proteins
  • Complement C1 Inhibitor Protein
  • Fibrin
  • MASP1 protein, human
  • MASP2 protein, human
  • Mannose-Binding Protein-Associated Serine Proteases